Sanjay S. Shukla
Overview
Sanjay S. Shukla received an average of $1M in total compensation, including $461K in salary, at aTYR PHARMA from 2016 to 2023.
2023aTYR PHARMAPresident and CEO
2022aTYR PHARMAPresident and CEO
2021aTYR PHARMAPresident and CEO
2020aTYR PHARMAPresident and CEO
2019aTYR PHARMAPresident and Chief Executive Officer
2018aTYR PHARMAPresident and CEO
2017aTYR PHARMAPresident and CEO
2016aTYR PHARMAChief Medical Officer
Source: SEC filings on April 5, 2024, March 22, 2022, March 23, 2021, April 2, 2020, March 28, 2019, April 3, 2018, and March 30, 2017.
Related executives
We found nine more executives who work or worked at aTYR PHARMA.
Jill Broadfoot
aTYR PHARMA
Chief Financial Officer
Nancy Denyes
aTYR PHARMA
General Counsel
Ashraf Amanullah
aTYR PHARMA
Former Senior Vice President, Biologics, Development and Manufacturing
David King
aTYR PHARMA
Chief Scientific Officer
John Mendlein
aTYR PHARMA
Chief Executive Officer
Sanuj Ravindran
aTYR PHARMA
Former Chief Business Officer
Kelly Blackburn
aTYR PHARMA
Vice President, Clinical Affairs
David Weiner
aTYR PHARMA
Chief Medical Officer
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019